hMAO-B-IN-5

CAS No. 358343-63-2

hMAO-B-IN-5( —— )

Catalog No. M36046 CAS No. 358343-63-2

hMAO-B-IN-5 is a potent reversible and selective human monoamine oxidase hMAO-B inhibitor (IC50:0.12μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 109 In Stock
5MG 93 In Stock
10MG 139 In Stock
25MG 224 In Stock
50MG 306 In Stock
100MG 421 In Stock
200MG 570 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    hMAO-B-IN-5
  • Note
    Research use only, not for human use.
  • Brief Description
    hMAO-B-IN-5 is a potent reversible and selective human monoamine oxidase hMAO-B inhibitor (IC50:0.12μM).
  • Description
    hMAO-B-IN-5(B15) is a potent, selective and reversible inhibitor of human monoamine oxidase hMAO-B with IC50 of 0.12 μM. hMAO-B-IN-5 can pass through the blood-brain barrier and can be used in the research of neurodegenerative diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MAO
  • Recptor
    MAO | Monoamine Oxidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    358343-63-2
  • Formula Weight
    358.43
  • Molecular Formula
    C24H22O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOC1=CC=C(C=C1)C(=O)\C=C\C1=CC=C(OCC2=CC=CC=C2)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sachithra Thazhathuveedu Sudevan, et al. Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors. Sci Rep. 2022 Dec 27;12(1):22404.??
molnova catalog
related products
  • rosmarinate acid

    Rosmarinate acid inhibits MAO-A, MAO-B and COMT enzymes with IC50s of 50.1, 184.6 and 26.7 μM, respectively

  • Osthenol

    Osthenol is a natural product, and is selective, reversible, and competitive human monoamine oxidase-A (hMAO-A) inhibitor (Ki=0.26 μM).

  • Femoxetine

    Femoxetine is a 5-HT inhibitor with antidepressant activity that potentiates morphine-induced anti-injury feelings and inhibits MAO-A and MAO-B required for the production of high exercise capacity in mice.